Noubar Afeyan, Director at Moderna, Inc. (MRNA), sold 399,244 shares at $148.29 ($59.2M) on 2024-06-11, disclosed to the SEC on 2024-06-11.
Open-market sale of $59.2M MRNA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $148.29 | 31,531 | $4.7M | 7.9% |
| 2 | $148.29 | 31,531 | $4.7M | 7.9% |
| 3 | $148.29 | 163,649 | $24.3M | 41.0% |
| 4 | $148.29 | 163,649 | $24.3M | 41.0% |
| 5 | $149.40 | 1,232 | $184K | 0.3% |
| 6 | $149.40 | 6,420 |
| $959K |
| 1.6% |
| 7 | $149.40 | 1,232 | $184K | 0.3% |
| Total | $148.31 avg | 399,244 | $59.2M | 100% |
| Filing → |
| MRNA | SELL | 2025-12-15 | $1.4M | — | Filing → |
| MRNA | SELL | 2024-08-02 | $3.6M | — | Filing → |
| MRNA | SELL | 2024-07-26 | $2.9M | — | Filing → |